Mice with reduced NMDA receptor expression display behaviors related to schizophrenia (Q28510751)

25 January 2017

title

Mice with reduced NMDA receptor expression display behaviors related to schizophrenia (English)

1 reference

Glutamate receptor, ionotropic, NMDA1 (zeta 1)

25 January 2017

0 references

1 reference

GOA release 2020-03-11

M. G. Caron

1 reference

25 January 2017

A. R. Mohn

1 reference

25 January 2017

R. R. Gainetdinov

series ordinal

1 reference

25 January 2017

B. H. Koller

series ordinal

1 reference

25 January 2017

language of work or name

English

0 references

publication date

20 August 1999

1 reference

25 January 2017

1 reference

25 January 2017

1 reference

25 January 2017

1 reference

25 January 2017

page(s)

427–436

1 reference

The NMDA antagonist model for schizophrenia: promise and pitfalls.

25 January 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

MPTP lesions of the nigrostriatal dopaminergic projection decrease [3H]1-[1-(2-thienyl)cyclohexyl]-piperidine binding to PCP site 2: Further evidence that PCP site 2 is associated with the biogenic amine reuptake complex

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Receptor activity and turnover of dopamine and noradrenaline after neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Amphetamine psychosis: behavioral and biochemical aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Interactions between glutamatergic and monoaminergic systems within the basal ganglia-implications for schizophrenia and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Neurotransmitter aberrations in schizophrenia: New perspectives and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Effects of atypical antipsychotic agents on social behavior in rodents

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

The glutamatergic dysfunction hypothesis for schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Increased NMDA current and spine density in mice lacking the NMDA receptor subunit NR3A

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Abolition of anaphylaxis by targeted disruption of the high affinity immunoglobulin E receptor alpha chain gene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

MK-801 increases locomotor activity without elevating extracellular dopamine levels in the nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Modification of NMDA receptor channels and synaptic transmission by targeted disruption of the NR2C gene

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

The N-methyl-d-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Targeted disruption of NMDA receptor 1 gene abolishes NMDA response and results in neonatal death

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

New Antipsychotics: Classification, Efficacy, and Adverse Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Recent advances in the molecular biology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Glutamate in schizophrenia: clinical and research implications

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Dextroamphetamine. Evaluation of psychomimetic properties in man

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Catalepsy as a rodent model for detecting antipsychotic drugs with extrapyramidal side effect liability

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Reduced spontaneous activity of mice defective in the epsilon 4 subunit of the NMDA receptor channel

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

NMDA receptors and in vivo dopamine release in the nucleus accumbens and caudatus

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Recent advances in the phencyclidine model of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Locomotor activity in D2 dopamine receptor-deficient mice is determined by gene dosage, genetic background, and developmental adaptations

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Quantitative autoradiography of dopamine-D1 receptors, D2 receptors, and dopamine uptake sites in postmortem striatal specimens from schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Molecular diversity of the NMDA receptor channel

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Impairment of suckling response, trigeminal neuronal pattern formation, and hippocampal LTD in NMDA receptor epsilon 2 subunit mutant mice

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

The Mechanism of Action of Novel Antipsychotic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Effects of MK-801 on spontaneous and amphetamine-stimulated dopamine release in striatum measured with in vivo microdialysis in awake rats

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Glutamate receptors: brain function and signal transduction

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Fertility in schizophrenia: results from a contemporary US cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

The NMDA antagonist, dizocilpine, enhances cocaine reinforcement without influencing mesoaccumbens dopamine transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

PCP site 2: a high affinity MK-801-insensitive phencyclidine binding site

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Reduced hippocampal LTP and spatial learning in mice lacking NMDA receptor epsilon 1 subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Social class, marriage, and fertility in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Antipsychotic drug doses and neuroleptic/dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Schizophrenia and glutamatergic transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021

Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine.

1 reference

https://api.crossref.org/works/10.1016%2FS0092-8674%2800%2981972-8

7 January 2021